middle.news
How Atomo’s FebriDx FDA Bid Could Transform Infectious Disease Testing
9:57am on Wednesday 29th of October, 2025 AEDT
•
Healthcare
Read Story
How Atomo’s FebriDx FDA Bid Could Transform Infectious Disease Testing
9:57am on Wednesday 29th of October, 2025 AEDT
Key Points
FebriDx submitted for US FDA CLIA waiver with over 99% user concordance
Pascal cassette sales exceed $1 million since agreement with Lumos and PHASE
Active Syphilis test shows market-leading specificity in preliminary clinical data
HIV Self-Test launched on Chemist Warehouse ecommerce and orders from USAID
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Atomo Diagnostics (ASX:AT1)
OPEN ARTICLE